Shoulder Innovations (NYSE:SI – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Shoulder Innovations to related companies based on the strength of its analyst recommendations, dividends, valuation, profitability, earnings, risk and institutional ownership.
Volatility and Risk
Shoulder Innovations has a beta of -1.51, indicating that its stock price is 251% less volatile than the S&P 500. Comparatively, Shoulder Innovations’ peers have a beta of 2.58, indicating that their average stock price is 158% more volatile than the S&P 500.
Valuation and Earnings
This table compares Shoulder Innovations and its peers top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Shoulder Innovations | $47.32 million | -$40.36 million | -12.75 |
| Shoulder Innovations Competitors | $1.89 billion | $136.81 million | 5.74 |
Insider & Institutional Ownership
40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a summary of current recommendations for Shoulder Innovations and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Shoulder Innovations | 1 | 0 | 5 | 0 | 2.67 |
| Shoulder Innovations Competitors | 4320 | 10605 | 18414 | 839 | 2.46 |
Shoulder Innovations presently has a consensus price target of $25.75, indicating a potential upside of 24.70%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 26.25%. Given Shoulder Innovations’ peers higher possible upside, analysts plainly believe Shoulder Innovations has less favorable growth aspects than its peers.
Profitability
This table compares Shoulder Innovations and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Shoulder Innovations | -51.72% | -25.37% | -20.87% |
| Shoulder Innovations Competitors | -190.60% | -186.87% | -21.75% |
About Shoulder Innovations
Shoulder Innovations, Inc. is a medical technology company focused on developing and commercializing products for shoulder replacement surgery. Its offerings are designed for orthopedic surgeons treating patients with shoulder conditions that may require joint replacement. The company’s product portfolio includes shoulder implant systems such as its InSet glenoid and Catalyst reverse shoulder technologies, along with related surgical instruments. These products support different approaches to shoulder arthroplasty, including procedures that replace or reconstruct parts of the shoulder joint.
Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.
